These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 28461759)

  • 1. [Clinical Multi-features Analysis of Cystic Lung Adenocarcinoma 
and Construction of Invasive Risk Prediction Model].
    Wang Q; Fu C; Wang K; Ren Q; Chen A; Xu X; Chen L; Zhu Q
    Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):266-275. PubMed ID: 38769829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and computed tomography features associated with recurrence-free survival of patients with small-sized peripheral invasive lung adenocarcinoma after sublobectomy.
    Huo J; Luo T; Lv F; Li Q
    Quant Imaging Med Surg; 2023 Dec; 13(12):8144-8156. PubMed ID: 38106273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth characteristics of early-stage (IA) lung adenocarcinoma and its value in predicting lymph node metastasis.
    Liu M; Mu J; Song F; Liu X; Jing W; Lv F
    Cancer Imaging; 2023 Dec; 23(1):115. PubMed ID: 38041175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between iodine uptake, invasive CT features and pleural invasion in adenocarcinomas with pleural contact.
    Chen Y; Huang Q; Zhong H; Li A; Lin Z; Guo X
    Sci Rep; 2023 Sep; 13(1):16191. PubMed ID: 37758831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pattern of lymph node metastasis in peripheral pulmonary nodules patients and risk prediction models.
    Ke L; Ma H; Zhang Q; Wang Y; Xia P; Yu L; Lv W; Hu J
    Front Surg; 2022; 9():981313. PubMed ID: 36017514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapulmonic Cavity or Necrosis on Baseline CT Scan Serves as an Efficacy Predictor of Anti-PD-(L)1 Inhibitor in Advanced Lung Squamous Cell Carcinoma.
    Lu T; Zhang L; Chen M; Zheng X; Jiang K; Zheng X; Li C; Xiao W; Miao Q; Yang S; Lin G
    Cancer Manag Res; 2021; 13():5931-5939. PubMed ID: 34354375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminating Small-Sized (2 cm or Less), Noncalcified, Solitary Pulmonary Tuberculoma and Solid Lung Adenocarcinoma in Tuberculosis-Endemic Areas.
    Zhang J; Han T; Ren J; Jin C; Zhang M; Guo Y
    Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34064284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of morphological characteristics assessed by CT scan in patients with non-small cell lung cancer treated with nivolumab.
    Minemura H; Moriya H; Imai H; Sugiyama T; Yamada Y; Higuchi M; Kaira K; Ozaki Y; Kanazawa K; Yokouchi H; Kasai T; Kaburagi T; Suzuki H; Minato K; Shibata Y
    Thorac Cancer; 2020 Dec; 11(12):3521-3527. PubMed ID: 33044045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel biologic factors correlated to visceral pleural invasion in early-stage non-small cell lung cancer less than 3 cm.
    Deng HY; Li G; Luo J; Alai G; Zhuo ZG; Lin YD
    J Thorac Dis; 2018 Apr; 10(4):2357-2364. PubMed ID: 29850141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and radiological characteristics of central pulmonary adenocarcinoma: a comparison with central squamous cell carcinoma and small cell lung cancer and the impact on treatment response.
    Wang Z; Li M; Huang Y; Ma L; Zhu H; Kong L; Yu J
    Onco Targets Ther; 2018; 11():2509-2517. PubMed ID: 29765230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy.
    Yamamoto T; Kadoya N; Shirata Y; Koto M; Sato K; Matsushita H; Sugawara T; Umezawa R; Kubozono M; Ishikawa Y; Kozumi M; Takahashi N; Ito K; Katagiri Y; Takeda K; Jingu K
    Radiat Oncol; 2015 Feb; 10():35. PubMed ID: 25886315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of visceral pleura invasion in non-small cell lung cancer.
    Kang JH; Kim KD; Chung KY
    Eur J Cardiothorac Surg; 2003 Jun; 23(6):865-9. PubMed ID: 12829059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of visceral pleural invasion in node-negative non-small cell lung cancer: a systematic review and meta-analysis.
    Jiang L; Liang W; Shen J; Chen X; Shi X; He J; Yang C; He J
    Chest; 2015 Oct; 148(4):903-911. PubMed ID: 25675151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between computed tomography morphology and prognosis of patients with stage I non-small cell lung cancer.
    Ma J; Yang YL; Wang Y; Zhang XW; Gu XS; Wang ZC
    Onco Targets Ther; 2017; 10():2249-2256. PubMed ID: 28461759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposal on incorporating blood vessel invasion into the T classification parts as a practical staging system for stage I non-small cell lung cancer.
    Kudo Y; Saji H; Shimada Y; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Lung Cancer; 2013 Aug; 81(2):187-93. PubMed ID: 23664031
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.